Liquid and Tissue Biopsies for Lung Cancer: Algorithms and Perspectives
Cancers · 29.09.2024 · 16 (19) · 3340
DOI: 10.3390/cancers16193340 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 29.09.2024. Verfasst von Paul Hofman. Beteiligte Einrichtung: IHU RespirERA, Côte d'Azur University, 30 Avenue de la Voie Romaine, 06002 Nice Cedex 01, France. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: IHU RespirERA, French government managed by “Agence. Nationale de la Recherche”, FHU OncoAge.
Abstract (Originalsprache)
The targeted therapies and immunotherapies in thoracic oncology, particularly for NS-NSCLC, are associated with an increase in the number of predictive biomarkers to be assessed in routine clinical practice. These treatments are administered thanks to marketing authorization for use in daily practice or are evaluated during clinical trials. Since the molecular targets to be identified are more and more complex and numerous, it is now mandatory to use NGS. NGS can be developed from both tissue and fluid (mainly blood). The blood tests in oncology, so-called “liquid biopsies” (LB), are performed with plasmatic circulating free DNA (cf-DNA) and are complementary to the molecular testing performed with a TB. LB use in lung cancer is associated with international guidelines, but additional algorithms could be set up. However, even if useful for better care of patients, notably with advanced and metastatic NS-NSCLC, until now LB are not often integrated into daily practice, at least in Europe and notably in France. The purpose of this review is to describe the different opportunities and algorithms leading to the identification of the molecular signature of NS-NSCLC, using both tissue and liquid biopsies, and to introduce the principle limitations but also some perspectives in this field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IHU RespirERA, Côte d'Azur University, 30 Avenue de la Voie Romaine, 06002 Nice Cedex 01, France.
- Laboratoire de Pathologie Clinique et Experimentale, Centre Hospitalier Universitaire de Nice, Hospital-Related Biobank (BB-0033-00025), Côte d'Azur University, 30 Avenue de la Voie Romaine, 06002 Nice Cedex 01, France.
- FHU OncoAge, Pasteur Hospital, Côte d'Azur University, 30 Avenue de la Voie Romaine, 06002 Nice Cedex 01, France.
ORCID-Profile: Paul Hofman
Förderung
- IHU RespirERA
- French government managed by “Agence. Nationale de la Recherche”
- FHU OncoAge
Zitieren
APA
Hofman, P. (2024). Liquid and Tissue Biopsies for Lung Cancer: Algorithms and Perspectives. Cancers, 16(19), 3340. https://doi.org/10.3390/cancers16193340
Vancouver
Hofman P. Liquid and Tissue Biopsies for Lung Cancer: Algorithms and Perspectives. Cancers. 2024;16(19):3340. doi:10.3390/cancers16193340
BibTeX
@article{Hofman2024,
author = {Hofman, Paul},
title = {Liquid and Tissue Biopsies for Lung Cancer: Algorithms and Perspectives},
journal = {Cancers},
year = {2024},
volume = {16},
number = {19},
pages = {3340},
doi = {10.3390/cancers16193340}
}
EUVIMED